Blog
RSS FeedPosted by Michael Wonder on 19 Jun 2023
SMC publishes a Collaborative Advice Document for tixagevimab-cilgavimab (Evusheld) for prevention of COVID-19
14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19. ...
Posted by Michael Wonder on 18 Aug 2022
Chiesi’s Trimbow recommended for use within NHS Scotland
18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...
Posted by Michael Wonder on 09 Feb 2021
Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide
8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...
Posted by Michael Wonder on 12 Aug 2019
‘Not acceptable’ disappointment as cystic fibrosis drug not approved in Scotland
12 August 2019 - People with cystic fibrosis in Scotland will continue to be denied potentially life-extending drugs after they ...
Posted by Michael Wonder on 12 Aug 2019
Cystic fibrosis drugs rejected for use by NHS in Scotland
12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland. ...
Posted by Michael Wonder on 12 Jun 2018
Cystic fibrosis patient backs campaign to make medicines available on NHS
10 June 2018 - A cystic fibrosis patient is calling for a medicine to be made available on the NHS ...
Posted by Michael Wonder on 11 Apr 2017
People at risk of HIV in Scotland to be given PrEP drug on NHS
11 April 2017 - AIDS campaigners say move puts pressure on England to end delays in providing the medication despite two ...